Methylphenidate has potential for abuse because it produces behavioural effects similar to those observed with other abused stimulants, such as d-amphetamine and cocaine. The aim of this study was to further characterize the abuse potential of oral methylphenidate relative to oral d-amphetamine. Ten drug-abusing volunteers were recruited to participate in this study, which consisted of seven dose conditions: methylphenidate (16, 32 and 48 mg), d-amphetamine (8, 16 and 24 mg) and placebo. The reinforcing effects of these drugs were assessed during a self-administration session (preceded by a sampling session for each condition) with a modified progressive-ratio procedure. Subject-rated, performance and physiological effects were assessed concurrently during both the sampling and self-administration sessions. The intermediate dose of methylphenidate and d-amphetamine increased responding significantly above placebo levels. Both methylphenidate and d-amphetamine produced dose-dependent increases in stimulant-like subject ratings (e.g. Active, Alert, or Energetic and High), but the effects of these drugs were not isomorphic. These findings are consistent with epidemiological data and previous findings from laboratory studies that suggest methylphenidate has at least some abuse potential.
Abreu M E , Griffiths R R (1996) Drug tasting may confound human drug discrimination studies . Psychopharmacology125: 255-257
2.
Abreu M E , Bigelow G E , Fleisher L , Walsh S L (2001) Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans . Psychopharmacology154: 76-84
3.
Babcock Q , Byrne T (2000) Student perceptions of methylphenidate abuse at a public liberal arts college . J Am Coll Health49: 143-145
4.
Brown W A , Corriveau D P , Ebert M H (1978) Acute physiologic and neuroendocrine effects of dextroamphetamine and methylphenidate . Psychopharmacology58: 189-195
5.
Chait L D (1993) Factors influencing the reinforcing and subjective effects of d-amphetamine in humans . Behav Pharmacol4: 191-199
6.
Chait L D (1994) Reinforcing and subjective effects of methylphenidate in humans . Behav Pharmacol5: 281-289
7.
Comer S D , Collins E D , Fischman M W (1997) Choice between money and intranasal heroin in morphine maintained humans . Behav Pharmacol8: 677-690
8.
Comer S D , Collins E D , Wilson S T , Donovan M R , Foltin R W , Fischman M W (1998) Effects of an alternative reinforcer on intravenous heroin self-administration by humans . Eur J Pharmacol345: 13-26
9.
Comer S D , Collins E D , MacArthur R B , Fischman M W (1999) Comparison of intranasal heroin self-administration by morphine-maintained humans . Psychopharmacology143: 327-338
10.
de la Garza R , Johanson C E (1986) Discriminative stimulus effects of intragastrically administered d-amphetamine and pentobarbital in rhesus monkeys . J Pharmacol Exp Ther243: 955-962
11.
de Wit H , Griffiths R R (1991) Testing the abuse liability of anxiolytic and hypnotic drugs in humans . Drug Alcohol Depend28: 83-111
12.
Di Marino M E , Haberny K A , Felch L J , Walsh S L , Preston K L , Bigelow G W (1998) Development of a subjective rating scale sensitive to acute cocaine administration . National Institute on Drug Abuse Research Monograph Series, Problems of Drug Dependence, 1997: Proceedings of the 59th Annual Meeting 178: 139
13.
Evans S M , Johanson C E (1987) Amphetamine-like effects of anorectics and related compounds in pigeons . J Pharmacol Exp Ther241: 817-825
14.
Fischman M W , Johanson C E (1998) Ethical and practical issues involved in behavioral pharmacology research that administers drugs of abuse to human volunteers . Behav Pharmacol97: 479-498
15.
Foltin R W , Fischman M W (1991) Assessment of abuse liability of stimulant drugs in humans: a methodological review . Br J Addict86: 1633-1640
16.
Griffiths R R , Bigelow G E , Liebson I A , O’Keefe M , O’Leary D , Russ N (1986) Human coffee drinking: Manipulation of concentratio and caffeine . J Exp Anal Behav45: 133-148
17.
Griffiths R R , Bigelow G E , Ator N A (2003) Principles of initial experimental drug abuse liability assessment in humans . Drug Alcohol Depend70: S41-S54
18.
Heishman S J , Henningfield J E (1991) Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans . Psychopharmacology103: 436-442
19.
Hoffman B B , Lefkowitz R J (1996) Catecholamines and sympathomimetic drugs. In Hardman JG , Limbird LE , Molinoff P B , Ruddon R W , Gilman A G (eds), Goodman and Gilman’s the pharmacological basis of therapeutics, 9th edn.Pergamon, New York
20.
Huang J T , Ho B T (1974) Discriminative stimulus properties of D-amphetamine and related compounds in rats . Pharmacol Biochem Behav2: 669-673
21.
Kollins S H , Rush C R , Pazzaglia P J , Ali J A (1998) Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate . Exp Clin Psychopharmacol6: 367-374
22.
Indiana Resource Prevention Center (2002) Alcohol, tobacco, and other drug use by Indiana children and adolescents, 2002. Institute for Drug Abuse Prevention, Bloomington, IN . http://www.drugs.indiana.edu/drug_stats/youth2002/life-12-2002.html (accessed 5 June 2003)
23.
Jasinski D R (1977) Assessment of the abuse potentiality of morphine-like drugs (methods used in man). In Martin W R (ed.), Handbook of experimental pharmacology. Springer, Berlin
24.
Koelega H S (1993) Stimulant drugs and vigilance performance: a review . Psychopharmacology111: 1-16
25.
Lin J S , Hou Y , Jouvet M (1996) Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat . Proc Natl Acad Sci USA93: 128-133
26.
Martin W R , Sloan J W , Sapira J D , Jasinski D R (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man . Clin Pharmacol Ther12: 245-258
27.
McLeod D R , Griffiths R R , Bigelow G E , Yingling J E (1982) An automated version of the digit symbol substitution test (DSST) . Behav Res Meth Instrum14: 463-466
28.
Negus S S , Mello N K , Lukas S E , Mendelson J H (1995) Diurnal patterns of cocaine and heroin self-administration in rhesus monkeys responding under a schedule of multiple daily sessions . Behav Pharmacol6: 763-775
29.
Oliveto A H , Bickel W K , Hughes J R , Shea P J , Higgins S T , Fenwick J W (1992) Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports . J Pharmacol Exp Ther261: 885-894
30.
Richardson N R , Roberts D C (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy . J Neurosci Meth66: 1-11
31.
Risner M E , Jones B E (1975) Self-administration of CNS stimulants by the dog . Psychopharmacologia43: 207-213
32.
Risner M E , Jones B E (1976) Characteristics of unlimited access to self-administered stimulant infusions in dogs . Biol Psychiatry11: 625-634
33.
Ritz M C , Lamb R J , Goldberg S R , Kuhar M J (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine . Science237: 1219-1223
34.
Roache J D , Grabowski J , Schmitz J M , Creson D L , Rhoades H M (2000) Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment . J Clin Psychopharmacol20: 61-68
35.
Rose J E , Corrigall W A (1997) Nicotine self-administration in animals and humans: similarities and differences . Psychopharmacology130: 28-40
36.
Rosen J B , Young A M , Beuthin F C , Louis-Ferdinand R T (1985) Discriminative stimulus properties of amphetamine and other stimulants in lead-exposed and normal rats . Pharmacol Biochem Behav24: 211-215
37.
Rush C R , Baker R W (2001) Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers . Exp Clin Psychopharmacology9: 59-73
38.
Rush C R , Kollins S H , Pazzaglia P J (1998) Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion and triazolam in d-amphetamine trained humans . Exp Clin Psychopharmacol6: 32-44
39.
Rush C R , Essman W D , Simpson C A , Baker R W (2001) Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing volunteers . J Clin Psychopharmacology21: 273-286
40.
Rush C R , Stoops W W , Hays L R , Glaser P E A , Hays L S (2003) Risperidone attenuates the discriminative-stimulus and subject-rated effects of d-amphetamine . J Pharmacol Exp Ther306: 195-204
41.
Schuster C R , Johanson C E (1988) Relationship between the discriminative stimulus properties and subjective effects of drugs. In: Colpaert F C , Balster R L (eds), Transduction mechanisms of drug stimuli. Springer, Berlin
42.
Selzer M L (1971) The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument . Am J Psychiatry127: 1653-1658
43.
Skinner H A (1982) The drug abuse screening test . Addict Behav7: 636-371
44.
Smith R C , Davis J M (1977) Comparative effects of D-amphetamine, L-amphetamine, and methylphenidate in man . Psychopharmacology53: 1-12
45.
Silverman P B , Ho B T (1980) The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine . Psychopharmacology68: 209-215
46.
Stafford D , LeSage M G , Glowa J R (1998) Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review . Psychopharmacology139: 169-184
47.
Stoops W W , Glaser P E A , Rush C R (2003) Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate: A dose-response analysis . Drug Alcohol Depend71: 179-186
48.
Stoops W W , Glaser P EA, Lile JA, Rush C R (2004) Discriminative-stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans . Exp Clin Psychopharmacol, in press
49.
Stoops W W , Lile J A , Fillmore M T , Glaser P EA, Rush C R (2004) Reinforcing effects of methylphenidate: Influence of dose and behavioral demands following drug administration . Psychopharmacol, in press
50.
Walker D J , Zacny J P (2003) Bitonic dose-response functions for reinforcing and self-reported effects of nitrous oxide in humans . Pharmacol Biochem Behav74: 851-857
51.
Walsh S L (1998) Behavioral pharmacology of cocaine. In Tarter R E , Ammerman R T and Ott P J (eds), Handbook of substance abuse: neurobehavioral pharmacology. Plenum Press, New York
52.
Watkins S S , Epping-Jordan M P , Koob G F , Markou A (1999) Blockade of nicotine self-administration with nicotinic antagonists in rats . Pharmacol Biochem Behav62: 743-751
53.
Winer B J (1971) Statistical principles in experimental design. McGraw-Hill, New York
